HCW Biologics Inc (NASDAQ:HCWB) currently has a daily average trading volume of 15.62M but it saw 1297739 shares traded in last market. With a market cap of 16.25M USD, the company’s current market price of $0.43 came rising about 0.19 while comparing to the previous closing price of $0.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.52 and as low as $0.21. In the recent trading on the day, stock has struck highest price mark of $0.3804 while lowest mark touched by it was $0.4631.
Taking a look at 20-day trading activity of HCW Biologics Inc (HCWB) gives us an average price of $0.3725, while its current price level is -82.95% below from 52-week high level whereas it is 104.28% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4139 while that of 200 days or SMA-200 reads an average of $0.6537. A closer look into the stock’s movement over the week reveals that its volatility is standing at 34.73% during that period while stretching the period over a month that decreases to 19.07%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.52 which implies that the stock is in neutral territory.
Over the week, HCWB’s stock price is moving 56.33% up while it is 6.07% when we observe its performance for the past one month. Year-to-date it is -3.70% down and over the past year, the stock is showing a downside performance of -62.97%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. Moreover, analysts are in estimates of $7M for current-quarter revenue.
Currently, HCW Biologics Inc’s total number of outstanding shares is 37.82M with 52.30% of that held by the insiders while 3.13% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -537.24%. Stock’s beta reads 0.78. Stock has a price to sale or P/S ratio amounts to 4.64. Its return on asset (ROA) is -120.09% on average.
